Amundi
CDLX icon

Amundi’s Cardlytics CDLX Stock Holding History

Amundi’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-742
Closed -$70K – 1915
2022
Q3 		$70K Buy
742
+392
+112% +$55.8K ﹤0.01% 1612
2022
Q2 		$48K Buy
350
+139
+66% +$46.5K ﹤0.01% 1542
2022
Q1 		$105K Buy
211
+20
+10% +$12.1K ﹤0.01% 1462
2021
Q4 		$129K Hold
191
– – ﹤0.01% 1538
2021
Q3 		$160K Buy
191
+38
+25% +$38.6K ﹤0.01% 1470
2021
Q2 		$194K Buy
+153
New +$173K ﹤0.01% 1383

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
GEH
General Equity Holdings Brooklyn, New York $135M AUM 32.96% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return

Amundi's CDLX Position: Q4 2022 in Review

Amundi sold out of Cardlytics (CDLX) in Q4 2022, closing a stake of 742 shares — an estimated $70K sold.

Amundi first reported a position in CDLX in Q2 2021 and held it in 6 quarters. The position peaked at $194K in Q2 2021. 121 funds tracked by Wall St. Rank hold CDLX as of Q4 2022.

  • Amundi reported no remaining Cardlytics position as of Q4 2022 after selling out during the quarter.
  • Amundi sold 742 Cardlytics shares in Q4 2022, an estimated $70K.
  • Amundi first reported a position in Cardlytics in Q2 2021 and held it in 6 quarters.
  • Amundi's Cardlytics position peaked at $194K in Q2 2021.
  • 121 funds tracked by Wall St. Rank held Cardlytics as of Q4 2022.

Based on Amundi's 13F filing for Q4 2022, filed 14 Feb 2023.